Genome-wide association meta-analysis of age at first cannabis use.

Addiction
Authors
Keywords
Abstract

BACKGROUND AND AIMS: Cannabis is one of the most commonly used substances among adolescents and young adults. Earlier age at cannabis initiation is linked to adverse life outcomes, including multi-substance use and dependence. This study estimated the heritability of age at first cannabis use and identified associations with genetic variants.

METHODS: A twin-based heritability analysis using 8055 twins from three cohorts was performed. We then carried out a genome-wide association meta-analysis of age at first cannabis use in a discovery sample of 24 953 individuals from nine European, North American and Australian cohorts, and a replication sample of 3735 individuals.

RESULTS: The twin-based heritability for age at first cannabis use was 38% [95% confidence interval (CI) = 19-60%]. Shared and unique environmental factors explained 39% (95% CI = 20-56%) and 22% (95% CI = 16-29%). The genome-wide association meta-analysis identified five single nucleotide polymorphisms (SNPs) on chromosome 16 within the calcium-transporting ATPase gene (ATP2C2) at P  5E-08. All five SNPs are in high linkage disequilibrium (LD) (r  > 0.8), with the strongest association at the intronic variant rs1574587 (P = 4.09E-09). Gene-based tests of association identified the ATP2C2 gene on 16q24.1 (P = 1.33e-06). Although the five SNPs and ATP2C2 did not replicate, ATP2C2 has been associated with cocaine dependence in a previous study. ATP2B2, which is a member of the same calcium signalling pathway, has been associated previously with opioid dependence. SNP-based heritability for age at first cannabis use was non-significant.

CONCLUSION: Age at cannabis initiation appears to be moderately heritable in western countries, and individual differences in onset can be explained by separate but correlated genetic liabilities. The significant association between age of initiation and ATP2C2 is consistent with the role of calcium signalling mechanisms in substance use disorders.

Year of Publication
2018
Journal
Addiction
Volume
113
Issue
11
Pages
2073-2086
Date Published
2018 11
ISSN
1360-0443
DOI
10.1111/add.14368
PubMed ID
30003630
PubMed Central ID
PMC7087375
Links
Grant list
R01 HD042157 / HD / NICHD NIH HHS / United States
R01 DA018267 / DA / NIDA NIH HHS / United States
DA-018673 / DA / NIDA NIH HHS / United States
R01 DA018673 / DA / NIDA NIH HHS / United States
R01 DA018660 / DA / NIDA NIH HHS / United States
G0800612 / MRC_ / Medical Research Council / United Kingdom
RC2 MH089951 / MH / NIMH NIH HHS / United States
RC2 DA028909 / DA / NIDA NIH HHS / United States
R01 AA007535 / AA / NIAAA NIH HHS / United States
R01 DA035804 / DA / NIDA NIH HHS / United States
R01 AA014041 / AA / NIAAA NIH HHS / United States
R01 MH081802 / MH / NIMH NIH HHS / United States
K05 AA017688 / AA / NIAAA NIH HHS / United States
N01HG65403 / HG / NHGRI NIH HHS / United States
R01 DA012690 / DA / NIDA NIH HHS / United States
RC2 MH089995 / MH / NIMH NIH HHS / United States
R01 DA012849 / DA / NIDA NIH HHS / United States
P50 AA011998 / AA / NIAAA NIH HHS / United States
Foundation Volksbond Rotterdam / International
R01 AA007728 / AA / NIAAA NIH HHS / United States
MC_UU_12013/6 / MRC_ / Medical Research Council / United Kingdom
R01 DA023668 / DA / NIDA NIH HHS / United States
R01 DA021905 / DA / NIDA NIH HHS / United States
R01 DA021913 / DA / NIDA NIH HHS / United States
R56 DA012854 / DA / NIDA NIH HHS / United States
T32 AA007580 / AA / NIAAA NIH HHS / United States
MC_UU_00011/1 / MRC_ / Medical Research Council / United Kingdom
R01 AA009203 / AA / NIAAA NIH HHS / United States
R37 DA018673 / DA / NIDA NIH HHS / United States
R01 AA013321 / AA / NIAAA NIH HHS / United States
R01 DA018432 / DA / NIDA NIH HHS / United States
MR/L022206/1 / MRC_ / Medical Research Council / United Kingdom
K02 AA018755 / AA / NIAAA NIH HHS / United States
R01 DA012845 / DA / NIDA NIH HHS / United States
U24 MH068457 / MH / NIMH NIH HHS / United States
R01 AA011330 / AA / NIAAA NIH HHS / United States
R01 DA012854 / DA / NIDA NIH HHS / United States
K05 AA000145 / AA / NIAAA NIH HHS / United States
R01 AA017535 / AA / NIAAA NIH HHS / United States
R01 AA010249 / AA / NIAAA NIH HHS / United States
NARSAD Young Investigator Grant / Brain & Behavior Research Foundation / International
R00 DA023549 / DA / NIDA NIH HHS / United States
K08 DA019951 / DA / NIDA NIH HHS / United States
R01 AA012502 / AA / NIAAA NIH HHS / United States
G0802736 / MRC_ / Medical Research Council / United Kingdom
Wellcome Trust / United Kingdom
R01 AA015416 / AA / NIAAA NIH HHS / United States
R37 AA007728 / AA / NIAAA NIH HHS / United States
R00DA023549 / US National Institutes of Health, National Institute on Drug Abuse / International
MC_UU_00011/7 / MRC_ / Medical Research Council / United Kingdom
U01 MH094432 / MH / NIMH NIH HHS / United States
NWO 480-05-003 / NWO / International
ERC-284167 / ERC_ / European Research Council / International
R01 AA013320 / AA / NIAAA NIH HHS / United States
P60 DA011015 / DA / NIDA NIH HHS / United States
R37 AA012502 / AA / NIAAA NIH HHS / United States
MR/K023233/1 / MRC_ / Medical Research Council / United Kingdom